Attachment_1_-_SOW.pdf

PDF 134 KB Posted Jun 9, 2017

Attached to: Drug Information Source for MedlinePlus Federal contract opportunity
Solicitation number: NIHLM2017948MM
Issued by: Department of Health and Human Services National Institutes of Health National Library of Medicine

About this file

From the source

STATEMENT OF WORK

View the file

Other files for this federal contract opportunity

Other files attached to Drug Information Source for MedlinePlus, newest first.
File	Type	Posted
RFP_Amendment_1_NIHLM2017948MM.pdf	PDF	Jun 20, 2017
Attachment_5_-_T&C.pdf	PDF	Jun 9, 2017
Attachment_6_-_Addendum.pdf	PDF	Jun 9, 2017
Attachment_4_-_TEC.pdf	PDF	Jun 9, 2017
Attachment_7_-_Invoice_and_Payment_Provisions.pdf	PDF	Jun 9, 2017
Attachment_3_-_GPAT.docx	DOCX document	Jun 9, 2017
Attachment_2_-_SF_1449.pdf	PDF	Jun 9, 2017

On GovTribe

Work with this file on GovTribe

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Statement	of	Work
Drug	Information	Source	for	MedlinePlus
National	Library	of	Medicine

Background

Information

assist

consumers

obtaining

the

information

they

need

make

informed

decisions

about

health

care,

the

National

Library

Medicine

(NLM)

has

developed

MedlinePlus

(medlineplus.gov),

easily

understandable

Web

resource

for

the

public.

MedlinePlus

contains

and

links

information

from

authoritative

health

Web

sites

and

content

providers,

especially

those

from

the

National

Institutes

Health.

NLM

makes

MedlinePlus

available

the

public

through

variety

MedlinePlus‐branded

Web

sites,

Web

services,

Web

applications,

APIs,

and

social

media

communications,

XML

files

and

results.

This Statement of Work (SOW) addresses NLM’s need to license a drug information source for MedlinePlus.

Objective

The

National

Library

Medicine

(NLM)

intends

license

drug

information

English

and

Spanish

assist

the

public

locating

information

about

prescription

and

over‐the‐counter

medications

via

MedlinePlus.

NLM

makes

MedlinePlus

available

the

public

through

variety

MedlinePlus‐

branded

Web

sites,

Web

services,

Web

applications,

APIs,

and

social

media

communications,

XML

files

and

results.

3.		Mandatory	Content	Requirements
1. At	least	1,000	English	monographs.
2. Equivalent	content	in	Spanish.
3. The	ability	to	identify	equivalent	English	and	Spanish	monographs.	The	vendor	must

describe	how	they	associate	equivalent	English	and	Spanish	monographs	within	the	data
provided	for	each	monograph.

4. The

ability

toggle

between

all

English

and

Spanish

monographs

the

individual,

equivalent

monograph

level.

5. Coverage

both

prescription

and

over‐the‐counter

medications.

6. Coverage

both

single

ingredient

medications

and

combination

ingredient

medications.

7. Each

monograph

must

include

the

ingredient

(generic)

name

for

the

medication

that

used

the

United

States,

alternate

synonymous

medication

names,

when

applicable,

and

associated

brand

names

and

brand

names

combination

products

used

the

United

States.

8. A

stand‐alone

file

that

maps

all

the

relevant

RxNorm

Concept

Unique

Identifiers

(RXCUIs),

including,

minimum,

all

relevant

Semantic

Clinical

Dose

Form

(SCDF)

RXCUIs,

each

monograph.

The

file

must

include,

minimum,

the

monograph

ID,

the

English

monograph

name,

the

SCDF

RXCUI

and

the

SCDF

RXCUI

name.

the

English

and

Spanish

monograph

IDs

are

not

identical

for

equivalent

English/Spanish

monographs,

then

the

file

must

also

include

both

the

English

monograph

and

the

Spanish

monograph

and

must

indicate

the

equivalent

relationship

between

the

two.

The

file

must

delivered

the

same

time

the

monograph

updates,

and

the

file

must

reflect

the

most

recent

monograph

content.

RXCUI

mappings

embedded

within

each

individual

monograph

XML

file

are

also

acceptable.

Embedded

mappings

must

also

include,

minimum,

all

relevant

Semantic

Clinical

Dose

Form

(SCDF)

RXCUIs

for

the

given

monograph.

9. We

expect

that

RXCUI

mappings

will

identical

for

the

equivalent

English

Spanish

monographs.

there

ever

circumstance

where

the

mapping

would

differ

between

the

equivalent

English

Spanish

monographs,

the

vendor

must

describe

this

circumstance

and

how

they

handle

from

editorial

perspective

and

within

the

stand‐alone

mapping

file

embedded

mappings.

10. The

vendor

must

explain

their

process

mapping

monographs

RXCUIs

and

their

process

for

updating

and

maintaining

those

mappings.

11. Permission

for

NLM

display

excerpt

1‐2

sentences,

“snippet”,

English

and

Spanish

monographs,

the

MedlinePlus

Connect

Web

Applications.

Snippets

would

followed

“Read

More”

link

pointing

the

full‐text

monograph

the

MedlinePlus

website.

Permission

for

NLM

deliver

these

snippets

the

XML

returned

users

the

MedlinePlus

Connect

Web

Services.

12. All

content

must

free

commercial

endorsements

advertisements.

13. The

vendor

must

describe

the

typical

contents

each

monograph

each

class

monograph

there

are

multiple

classes

them.

Contents

may

include,

but

are

not

limited

to,

information

why

medication

prescribed,

how

used,

precautions,

side

effects,

interactions,

storage,

missed

doses

and

overdose

information.

The

vendor

must

list

the

topics

sections

that

they

cover

each

monograph

and

describe

the

contents

those

topics/sections.

14. The

vendor

must

describe

their

process

for

keeping

monograph

content

date.

15. The

vendor

must

describe

how

they

keep

with,

display,

and

make

editorial

decisions

about

FDA

warnings

the

monograph

level

for

both

English

and

Spanish

monographs.

Examples

warnings

include,

but

are

not

limited

to,

safety

alerts,

ongoing

safety

reviews,

safety

communications

and

notices

withdrawal

from

market.

16. The vendor must address whether they provide FDA approval status at the monograph level.

17. The

intended

audience

for

the

monographs

must

general

health

information

consumers

the

United

States.

The

vendor

must

describe

how

they

address

the

needs

U.S.

consumer

audience

their

writing

and

their

editorial

policies.

18. Monographs

must

written

consumer‐friendly

language.

the

response,

the

vendor

must

indicate

the

reading

grade

level.

The

vendor

must

include

the

measurement

scale

used

determine

the

reading

grade

level.

19. Spanish

monographs

must

culturally‐neutral

Spanish

appropriate

for

U.S.

consumer

audience,

not

written

narrated

the

style

vocabulary

particular

Spanish

speaking

nationality.

The

vendor

must

describe

their

translation

procedures,

including

quality

control

procedures.

20. The

vendor

must

deliver

updated

monograph

and

mapping

file

content

NLM

least

once

month.

The

response

must

include

the

vendor’s

regular

update

schedule

and

description

the

content

the

update

and

the

delivery

mechanism.

21. When

NLM

identifies

major

content

issues,

NLM

will

communicate

the

issue

with

the

vendor.

The

vendor

must

describe

their

procedure

and

turn‐around

time

for

content

updates,

including

procedures

and

timelines

for

emergency

content

updates.

22. NLM

will

forward

the

vendor

any

feedback

received

from

users

regarding

content.

The

vendor

must

describe

their

procedure

for

reviewing

this

feedback,

incorporating

this

feedback

into

their

editorial

cycle,

and

following‐up

with

NLM

any

action

taken.

Preferred

Content

Features

(not

mandatory)

1. Within

the

stand‐alone

file

that

maps

all

the

relevant

RXCUIs

within

the

RXCUIs

embedded

the

individual

monograph

XML

files,

additional

RXCUI

mappings

the

following

term

types

may

included

for

each

monograph.

Note:

SCDF

mappings

are

required.

See

“Mandatory

Content

Requirements”

above.

a) BPCK

–

Brand

Name

Pack

b) BN	–	Brand	Name
c) SCDC	–	Semantic	Clinical	Drug	Component
d) SCD	–	Semantic	Clinical	Drug
e) SBD	–	Semantic	Branded	Drug
f) SBDC	–	Semantic	Branded	Drug	Component
g) GPCK	–	Generic	Pack
h) SBDF	–	Semantic	Branded	Drug	Form

2. If

the

vendor

provides

the

RXCUI

mappings

stand‐alone

file,

the

stand‐alone

file

includes

the

Spanish

monograph

name

for

each

entry.

3. A

pronunciation

guide

for

the

monograph

name

(ingredient/generic

name).

4. Pill

images

with

meaningful

alt

text

both

English

and

Spanish.

The

vendor

must

provide

identifier

for

linking

the

pill

images

the

appropriate

English

Spanish

monographs.

the

vendor

offers

pill

images,

they

must

include

least

sample

images

with

their

proposal.

The

vendor

must

also

describe

demonstrate

how

they

associate

individual

pill

image

files

individual

English

and

Spanish

monograph

XML

files.

The

pill

images

must

delivered

the

same

time

the

monograph

updates,

and

the

pill

images

must

reflect

the

most

recent

monograph

content.

Image dimensions must be specified as well.

5. Citations	or	references,	with	PubMed	links,	in	each	monograph.
6. Relative	links	to	other	monographs	in	the	collection.
7. Indicate	any	other	special	features	available.

Mandatory

Technical

Requirements

1. Delivery

monographs

well‐formed,

valid

XML

format

with

accompanying

DTD

schema.

schema

preferred.

2. Delivery

individual

XML

files

for

each

monograph

each

language

–

One

XML

file

for

the

English

monograph

and

separate

XML

file

for

the

equivalent

Spanish

monograph.

3. Delivery

monograph‐to‐SCDF

RXCUI

mappings

stand‐alone

CSV

XML

file

(XML

preferred

but

CSV

acceptable)

embedded

within

each

individual

monograph

XML

file.

4. Allow

NLM

host

all

the

vendor‐provided

content

NLM

servers,

including

pill

images,

applicable.

5. Allow

for

MedlinePlus

co‐branding

drug

information

pages.

6. The

awardee

will

required

provide

NLM

with

technical

support

and

advanced

delivery

the

content

files

within

weeks

being

selected

NLM

that

NLM

can

implement

the

co‐branded

content

pages

and

links

these

pages

MedlinePlus‐branded

sites,

services

and

files.

7. When

NLM

identifies

major

technical

issues,

NLM

will

communicate

the

issue

with

the

vendor.

The

vendor

must

describe

their

procedure

and

turn‐around

time

for

technical

fixes,

including

procedures

and

timelines

for

emergency

fixes.

8. Accessibility

content:

All

electronic

content

must

meet

Section

508

Guidelines.

See

the

specific

requirements

regarding

Accessibility

Compliance

below.

5.1 Accessibility Requirements

Section

508

the

Rehabilitation

Act

requires

that

Federal

agencies'

electronic

and

information

technology

accessible

people

with

disabilities.

The

drug

Web

site

must

Section

508

compliant.

Specifically,

the

end

product

must

conformant

with

all

applicable

provisions,

including:

1194.22	Web‐based	intranet	and	internet	information	and	applications
1194.31	Functional	performance	criteria.
1194.41	Information,	documentation,	and	support.

Applicable clauses depend on the nature of the content. These provisions can be found at https://www.access‐board.gov/guidelines‐and‐standards/communications‐and‐it/about‐the‐ section‐508‐standards/section‐508‐standards

The

Section

508

‘Refresh’

will

effective

January

18,

2018.

The

Offeror

will

expected

provide

Information

and

Communications

Technology

(ICT)

that

complies

with

these

revised

section

508

standards

beginning

later

than

this

date.

The

new

Section

508

standards

largely

adopt

Level

and

conformance

the

World

Wide

Web

Consortium’s

Web

Accessibility

Initiative

(W3C‐WAI)

WCAG

2.0

standards,

and

also

extend

these

web

standards

documents

and

application

interfaces,

and

revamp

Section

255

Guidelines

the

Communications

Act

1934.

Section

508

conformance

includes

ensuring

that

all

content,

including

text,

all

non‐text

content

such

multimedia

and

images,

and

any

associated

players

viewers,

are

fully

accessible

per

Section

508

“Refresh”

and

WCAG

2.0

Level

and

standards.

This

includes

but

not

limited

ensuring

that

all

text

elements

are

captioned

and

synchronized

with

the

content

and

that

all

non‐

text

elements

are

fully

described,

including

any

images,

still

moving,

that

provide

context

the

meaning

the

content.

5.2

Accessibility

Program

Need

Requirements

for

accessibility

based

Section

508

the

Rehabilitation

Act

1973

(29

U.S.C.

794d)

are

determined

relevant

for

the

following

program

need:

"Drug

Information

Source

for

MedlinePlus."

5.3

Accessibility

Product

Requirements

1194.22,

1194.31

and

1194.41

from

CFR

part

1194

Subpart

have

been

determined

apply

this

acquisition.

Solicitation

respondents

must

describe

how

Information

and

Communication

Technology

deliverables

meet

least

these

requirements

identified

applicable

the

attached

Government

Product/Service

Accessibility

Template

(GPAT).

5.4

Accessibility

Evaluation

Factors

Responses

this

solicitation

will

only

considered

for

award

after

has

been

determined

that

the

proposal

adequately

addresses

the

requirements

for

Section

508.

Only

proposals

which

contain

adequate

information

document

their

responsiveness

the

Section

508

requirements

(e.g.

completed

GPAT)

will

eligible

for

any

additional

merit

consideration.

5.5

Accessibility

Acceptance

Criteria

The

drug

information

licensed

result

this

solicitation

will

accepted

based

part

satisfaction

identified

Section

508

requirements

for

accessibility.

The

drug

information

vendor

must

include

completed

GPAT,

sample

which

included

part

this

solicitation.

The

Offeror

should

complete

the

two

right‐hand

columns,

including

explanation

how

the

product

complies

with

the

clause.

the

deliverable

includes

features

and

functions

addition

those

identified

requirements,

these

features

and

functions

also

need

conform

relevant

Section

508

technical

provisions,

functional

performance

criteria,

and

information,

documentation

and

support.

Additional

Requirements

1. Features

and

product

offerings

will

evaluated

they

exist

the

time

proposal

submission. Beta releases and planned updates will not be considered.

2. Include

the

cost

for

licensing

this

product.

The

cost

must

annual

flat

fee

for

providing

the

content

users

any

MedlinePlus

branded

Web

site,

the

ability

for

end‐users

MedlinePlus‐branded

sites

print,

and

links

the

content

for

individual,

personal

use,

and

for

providing

links

the

content

any

MedlinePlus

branded

Web

service,

Web

application,

API,

and

social

media

communication,

XML

file

and

result.

3. Include

sample

license

agreement

governing

the

use

the

content

all

MedlinePlus‐

branded

Web

sites,

Web

services,

Web

applications,

APIs,

and

social

media

communications,

XML

files

and

results.

The

license

agreement

must

also

address

NLM’s

rights

the

sharing

links

the

content

MedlinePlus‐branded

sites,

services,

applications,

communications,

files

and

results.

4. Include

your

statement

and

any

required

disclaimers

both

English

and

Spanish.

5. If

the

vendor

requires

their

logo

displayed

all

vendor‐supplied

content

pages,

the

logo

must

smaller

than

70x70

pixels

and

NLM

must

allowed

determine

the

placement

the

logo

the

content

pages.

Include

sample

the

logo

(in

English

and

Spanish

the

logo

differs

each

language)

and

any

display

requirements.

6. Provide

list

least

three

other

organizations

that

license

the

content,

along

with

accompanying

Web

site

URLs.

Provide

least

three

references

that

NLM

can

contact.

7. Provide

copy

your

customer

service

policy,

other

evidence

your

commitment

customer

service.

8. Provide

copy

your

editorial

policies

and

procedures.

Also

include

the

names

and

affiliations

the

members

your

editorial

and/or

medical

board.

9. The

vendor

must

have

policies/procedures

place

regarding

the

quality

control

the

drug

information

and

associated

RXCUI

mapping

file.

Provide

these

policies/procedures

your

response.

10. Include

English

monographs

and

their

Spanish

equivalents

both

XML

format

and

example

the

final

presentation

format.

11. Include

your

schema

(preferred)

DTD.

12. Include

sample

the

stand‐alone

monograph‐to‐RXCUI

mapping

file

that

covers

least

10%

the

entire

monograph

collection

being

offered,

including

the

example

monographs

required

above.

the

RXCUI

mappings

will

embedded

the

monograph

XML,

provide

those

embedded

mappings

the

example

monographs

required

above.

7. Place of Performance

Files will be delivered or retrieved electronically.

8. Deliverables/Delivery Schedule

SOW TASK # Deliverable Title #Calendar Days After Award

15 Initial content file delivery 14 days after award

3 Content update At a mutually agreeable schedule

		3	Response	to	requests	for	emergency	updating
of	content

Within	a	mutually	agreeable
turn‐around	time

Inspection

and

Acceptance

Criteria

NLM

will

inspect

and

quality

review

the

delivered

content

part

the

regular

update

process.

10.

Other

Pertinent

Information

Special

Considerations

Features

and

product

offerings

will

evaluated

they

exist

the

time

proposal

submission.

Beta

releases

and

planned

updates

will

not

considered.

11.

Transition

Plan

The

awardee

will

required

provide

NLM

with

technical

support

and

advanced

delivery

the

content

files

within

days

being

selected

NLM

that

NLM

can

plan

for

the

implementation

the

content

pages

and

links

these

pages

MedlinePlus‐branded

sites,

services

and

files.

the

event

that

NLM

ceases

licensing

this

product,

the

Offeror

will

notified

within

calendar

days

the

change,

but

will

help

assist

with

the

transition

providing

technical

support

and

addressing

questions

that

facilitate

transitioning

new

provider

content.

The

contractor

shall

create

any

requested

non‐proprietary

documentation

that

NLM

requests

aid

with

the

transition.

Any

documentation

developed

for

this

purpose

shall

the

property

the

government.

File details come from the government source that posted it. Updated Nov 14, 2017.